VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $24,676 | -63.7% | 2,634 | -5.3% | 0.00% | – |
Q2 2023 | $67,892 | +23.9% | 2,780 | +18.5% | 0.00% | – |
Q1 2023 | $54,778 | -15.9% | 2,346 | -8.6% | 0.00% | – |
Q4 2022 | $65,164 | -10.7% | 2,566 | -31.7% | 0.00% | – |
Q3 2022 | $73,000 | +128.1% | 3,758 | +198.7% | 0.00% | – |
Q2 2022 | $32,000 | -87.8% | 1,258 | -84.5% | 0.00% | -100.0% |
Q1 2022 | $262,000 | -34.0% | 8,106 | -17.5% | 0.00% | 0.0% |
Q4 2021 | $397,000 | +15.7% | 9,826 | +9.4% | 0.00% | 0.0% |
Q3 2021 | $343,000 | +3.9% | 8,980 | +20.8% | 0.00% | 0.0% |
Q2 2021 | $330,000 | -11.1% | 7,431 | +0.3% | 0.00% | 0.0% |
Q1 2021 | $371,000 | -29.1% | 7,409 | -62.0% | 0.00% | 0.0% |
Q4 2020 | $523,000 | +868.5% | 19,510 | +1160.3% | 0.00% | – |
Q3 2020 | $54,000 | -53.8% | 1,548 | -46.1% | 0.00% | – |
Q2 2020 | $117,000 | +21.9% | 2,870 | +2.5% | 0.00% | – |
Q1 2020 | $96,000 | – | 2,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
Capital International Investors | 983,300 | $12,365,000 | 0.00% |
Blackstone Inc. | 35,000 | $440,000 | 0.00% |
Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |